Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03676738 · ClinicalTrials.gov registry record
Cohort Study of Risk Factors for Postoperative Cognitive Decline
A clinical trial, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- 125
- Enrollment target
NCT03676738: Completed study, sponsored by Oregon Health and Science University.
NCT03676738 is a clinical trial that has completed, run by Oregon Health and Science University. The registered enrollment target is 125 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03676738 has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- 125 participants
- Enrollment target
Study Summary
Presently, the role of either genetic factors or biological sex in the development of postoperative cognitive dysfunction (POCD) is unknown. There is a critical need to determine which individuals are at high-risk for developing POCD by virtue of biological sex or genetic predisposition. The knowledge gained in the described research has the potential to shed light on mechanistic pathways, a necessary next step in order to ultimately identify therapeutic strategies.
Primary Outcome
To determine whether specific genetic variables (i.e. APOE4 or PLA2 alleles) and/or biological sex confer a higher risk to developing postoperative cognitive and functional status decline in older adults.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2018-03-26 |
| Est. Completion | 2022-05-20 |
What the finished NCT03676738 record still lists
NCT03676738 is an observational study that tracks outcomes without assigning an intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03676738 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03676738 about?
NCT03676738 is a clinical study titled "Cohort Study of Risk Factors for Postoperative Cognitive Decline". Presently, the role of either genetic factors or biological sex in the development of postoperative cognitive dysfunction (POCD) is unknown. There is a critical need to determine which individuals are at high-risk for developing POCD by virtue of biological sex or genetic predisposition. The knowled...
What is the current status of trial NCT03676738?
This trial is currently completed. The enrollment target is 125 participants. The study started on 2018-03-26. Estimated completion is 2022-05-20.
Who is sponsoring clinical trial NCT03676738?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI